Based on the aggregated intelligence of 165,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical radiation equipment maker Accuray (Nasdaq: ARAY) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Accuray's business and see what CAPS investors are saying about the stock right now.

Accuray facts

Headquarters (Founded)

Sunnyvale, Calif. (1990)

Market Cap

$397 million


Health-care equipment

Trailing-12-Month Revenue

$219 million


CEO Dr. Euan Thomson (since 2002)

CFO Derek Bertocci (since 2009)

Return on Equity (Average, Past 3 Years)



$139 million / $0


Siemens (NYSE: SI)
Varian Medial Systems (NYSE: VAR)

Sources: Capital IQ (a division of Standard & Poor's) and Motley Fool CAPS.

On CAPS, 96% of the 556 members who have rated Accuray believe the stock will outperform the S&P 500 going forward. These bulls include lagunabb and 21popsontop.

Two months ago, CAPS investor lagunabb brought Accuray's recent landmark achievement to our community's attention: "200 systems installed is a big milestone and backlog is ramping faster than installations."

For the uninitiated, Accuray's CyberKnife is the world's only noninvasive robotic radiosurgery system designed to treat tumors anywhere in the body. The company can be described as a small fish swimming in a pond dominated by three sharks (Elekta, Siemens, and Varian), but a recent deal with one of those rivals has several Accuray bulls excited for bigger and better things.

In early June, Accuray announced an alliance with giant Siemens to help ramp up sales of CyberKnife. As part of the partnership, Siemens will receive the right to sell CyberKnife globally and will also purchase other Accuray technologies for use in its accelerator products. While Accuray has operated at a loss over the past year, our CAPS community believes the big distribution deal is yet another confirmation of CyberKnife's real potential, and, more importantly, another important step toward long-term value creation.

CAPS member 21popsontop, sums it up:

This longshot has an interesting product in CyberKnife and with a global distributional and mutual back scratching hook up with Siemens deserves a hard look while in the pennies. I will add though, in a market like this you just might get it cheaper with Management looking to the lower end of guidance.

What do you think about Accuray, or any other stock for that matter? If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future, and on Motley Fool CAPS, thousands of investors are working every day to find them. CAPS is 100% free, so get started!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Fool's disclosure policy always gets a perfect score.